retatrutide phase 3 trials Today, we shared new data from two of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide phase 3 #obesity #osteoarthritis

Visit the Official MEDVi Website to view the latest promotions, program details, and current pricing

Group yoga

Utilising our expertise and experience in medication adherence and patient compliance we acquire, monitor, analyse, guide and interpret data to deliver absolute clarity and bring confidence to sponsors, trialists, and ultimately, patients

In Mar26, BMS Sotyktu (Deucravacitinib) wins FDA approval to treat adults with active psoriatic arthritis (PsA) Total Revenue: $48.67B Founded Year: 1923 Total Employees: 69,200 Headquarters: Bagsvaerd, Denmark Market Cap: $127.23B Stock Exchange: CPH Novo Nordisk is a global healthcare company focused on diabetes, obesity, and rare diseases, with a strong leadership position in metabolic disorders driven by its GLP-1based therapies and innovation-led pipeline